Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 4 SMR in Patients Undergoing Primary PCI Based on Use of Eptifibatide and Abciximab
The observed mortality in patients treated with abciximab or eptifibatide was lower than the predicted mortality. The standardized mortality rates (SMR) (a ratio of observed mortality and predicted mortality) of patients treated with abciximab and eptifibatide were similar. PCI = percutaneous coronary intervention.
|
